A biological paradox offers new insights into the mystery of cancer

The cells in the body can be thought of as tiny archery targets, each vulnerable to the deadly arrow of cancer.  The more cells a given animal has and the

 A simple, marine-dwelling creature known as Trichoplax adhaerens has some remarkable properties. The organism can tolerate unusually high doses of radiation that would kill most other forms of life. T.

OncoMyx Therapeutics, an Arizona State University (ASU) spinout and privately-held oncolytic immunotherapy company founded on the myxoma virus (MYXV) platform, has finalized a licensing agreement with Skysong Innovations, ASU's technology transfer organization.

Study shows first applications of DNA origami for nanomedicine In a major advancement in nanomedicine, Arizona State University (ASU) scientists, in collaboration with researchers from the National Center for Nanoscience